Human stem cell neuronal differentiation on silk-carbon nanotube composite
© Chen et al; licensee Springer. 2012
Received: 25 November 2011
Accepted: 14 February 2012
Published: 14 February 2012
Skip to main content
© Chen et al; licensee Springer. 2012
Received: 25 November 2011
Accepted: 14 February 2012
Published: 14 February 2012
Human embryonic stem cells [hESCs] are able to differentiate into specific lineages corresponding to regulated spatial and temporal signals. This unique attribute holds great promise for regenerative medicine and cell-based therapy for many human diseases such as spinal cord injury [SCI] and multiple sclerosis [MS]. Carbon nanotubes [CNTs] have been successfully used to promote neuronal differentiation, and silk has been widely applied in tissue engineering. This study aims to build silk-CNT composite scaffolds for improved neuron differentiation efficiency from hESCs.
Two neuronal markers (β-III tubulin and nestin) were utilized to determine the hESC neuronal lineage differentiation. In addition, axonal lengths were measured to evaluate the progress of neuronal development. The results demonstrated that cells on silk-CNT scaffolds have a higher β-III tubulin and nestin expression, suggesting augmented neuronal differentiation. In addition, longer axons with higher density were found to associate with silk-CNT scaffolds.
Our silk-CNT-based composite scaffolds can promote neuronal differentiation of hESCs. The silk-CNT composite scaffolds developed here can serve as efficient supporting matrices for stem cell-derived neuronal transplants, offering a promising opportunity for nerve repair treatments for SCI and MS patients.
There are about 250,000 to 400,000 patients in the US suffering from spinal cord injury [SCI] , usually due to trauma or traffic accidents, which could lead to death or life-long paralysis. According to the National Multiple Sclerosis Society, there are about 400,000 multiple sclerosis [MS] patients in the US, and this number is steadily growing: about 200 people are diagnosed each week. Currently, there is no effective cure for SCI or MS since adult humans do not fully regenerate their damaged neurons and axons. The inability for the body to regenerate and re-innervate target neuronal axons greatly limits therapy feasibility [1, 2]. The unique abilities of human embryonic stem cells [hESCs] - namely, their self-renewal and potency - hold great promise for regenerative medicine. For SCI and MS patients, the capacity of hESCs to differentiate into specific neuronal lineages through effective induction is highly encouraging. The unique appeal of hESC-based transplantation for SCI and MS is the possibility of those transplanted cells to repair damaged neuronal tissues. However, the harsh microenvironment and the lack of supportive substrates during transplantation result in a low survival rate of transplanted cells and diminish the feasibility of stem cell-related cell therapy . In regenerative medicine and tissue engineering, both naturally derived and synthetic materials have been extensively explored and provided their respective advantages . For instance, nanofibers incorporated with the pentapeptide epitope, isolucine-lysin-valine-alanine-valine, were constructed to induce rapid differentiation of cells into neurons. Biomaterials synthesized with synthetic or natural polymers were fabricated to facilitate the complex tissue formations [4–9]. Generally, due to their inherent properties of biological recognition, extracted natural proteins present better cell-triggered proteolysis degradation and biocompatibility; synthetic materials provide more flexible material properties with specific designs. In this study, we aimed to integrate natural silk fibroin protein with synthetic carbon nanotubes [CNTs] to construct scaffolds for neuronal developments.
CNTs are a conductive biomaterial with sizes comparable to extracellular matrix molecules such as collagens and laminins, which have been reported to favor neuronal growth [10, 11]. In addition, due to their excellent mechanical strength and flexibility, CNTs can contribute to the structural integrity of scaffolds. Substrates prepared with CNTs have been demonstrated to be biocompatible and can support neuronal growth and differentiation . It has also been proposed that neurons grown on a CNT meshwork displayed better signal transmission, possibly due to tight contacts between the CNTs and neural membranes, favoring electrical shortcuts . All of the above characteristics make CNTs a promising biomaterial to repair damaged neuronal tissues.
Silks are natural polymers (protein) that have been widely used as biomaterials for many years. Fibroin protein is extracted from silk (Bombyx mori), consisting of 90% of amino acids such as glycine, alanine, and serine. Various ratios of amino acids are distributed on the supramolecular structure of fibroin, consisting of a hydrophobic heavy chain (350 kD to 370 kD) and hydrophilic light chain (25 kD) [13, 14]. Due to its mechanically robust and flexible nature in thin film form, biocompatibility, and in vivo reabsorbing and water-dissolvable properties, fibroin protein has been used as a building material for scaffolds for various tissue engineering applications and stem cell researches [8, 15–18]. For instance, fibroin scaffolds have been successfully applied to human mesenchymal stem cell differentiation, especially for ligament, bone, or cartilage tissue engineering [17, 19]. In addition, successful bio-integrated electronics has been developed based on dissolvable silk fibroin films .
Unmodified CNTs tend to aggregate rather than disperse in aqueous solutions due to their hydrophobic nature. These heterogeneous aggregations of CNTs not only bring about difficulties in scaffold preparation, but also limit their applications. In an effort to resolve this problem, various surfactants were adapted to disaggregate and uniformly disperse CNTs in different solvents. However, the bio-toxicity of residuals still remains as one of the major concerns for cell scaffolding fabrication [21–23]. Since fibroin consists of 75% of nonpolar hydrophobic amino acids , it has been shown that the amphiphilic fibroin protein can effectively serve as a dispersant for CNTs . Here, we used fibroin extraction to disperse CNTs homogeneously to build silk-CNT composite scaffolds. This study aims to combine the unique advantages of these two biocompatible materials to build silk-CNT scaffolds in order to acquire sufficient neuronal differentiation efficiency from hESCs for effective neuronal cell transplantation.
Based on the protocol published by Kaplan et al. [7, 8], B. mori silk was in boiling 0.02 M Na2CO3 (Sigma-Aldrich, St. Louis, MO, USA) for 1 h and rinsed thoroughly with deionized [DI] water to remove sericin protein associated with fibroin. The washed silk was then dissolved in 9.3 M LiBr (Fisher Scientific, Pittsburgh, PA, USA) for 3 h at 60°C. The fibroin solution was then dialyzed (MWCO 1,000, Spectrum Laboratories, Inc., Rancho Dominguez, CA, USA) in DI water for 48 h. Following which, the silk solution was centrifuged at 800 × g, and the supernatant was collected .
Multi-wall CNTs [MWCNTs] (Nano-Lab, Waltham, MA, USA) were dispersed in DI water and sonicated for 2 h to help disperse the MWCNT. Glass micro-coverslips were boiled in a mild surfactant for 30 min and rinsed with DI water. The coverslips were then washed with 2 N HCl overnight and cleaned with DI water. The concentration of the MWCNT/silk mixture was 1 mg/ml MWCNT in 2 wt.% silk fibroin solution. For the preparation of silk scaffolding, 600 μl of 2 wt.% silk fibroin solution was deposited on the coverslip surface at 60°C. Silk-CNT scaffolds were prepared with the silk-CNT mixed solution following a similar protocol. In order to increase cell attachment on silk fibroin , laminin (20 μg/ml, Sigma-Aldrich, St. Louis, MO, USA) was used to coat the scaffold surfaces . Poly-L-ornithine [PLO] (Sigma-Aldrich, St Louis, MO, USA), a common substrate for neuronal differentiation, was used as the control substrate coating. PLO solution (0.1 mg/ml) was applied to the coverslip surface and incubated at 37°C overnight. Excess PLO solution was aspirated; then, the surface was rinsed with DPBS before use . Silk-CNT substrates were exposed to UV for 1 h for sterilization purposes.
H9 hESC lines from Wicell (Madison, WI, USA; passage 32 to 55) were cultured on feeder layers of mitomycin C-treated mouse embryonic fibroblasts [MEFs] as described in our previous study . The medium was changed daily, and differentiated cells were moved manually after 7 days.
The hESC cell colonies were detached from the MEF feeder layer with dispase (1 U/ml) and transferred to ultra-low contact wells. The suspended hESCs aggregated as an embryoid body [EB] and was allowed to grow for 4 to 6 days before plating on substrates. With respect to the influence of cell density on differentiations, seven to ten EB cell aggregations were seeded onto each PLO, silk, and silk/CNT substrates, with a neuron induction medium consisting of F12/DMEM, N2 supplement, and FGF2 (20 ng/ml). The medium was changed once daily for the first 2 days and then once every other day.
We stained cells using β-III tubulin (Millipore Co., Billerica, MA, USA) as a marker for neuronal differentiation with a ratio of 1:500, nestin (Millipore Co., Billerica, MA, USA) as markers for motor neuron progenitor , and DAPI (Invitrogen, Carlsbad, CA, USA) as nuclei markers. Cells were fixed with 4% paraformaldehyde on the seventh day for immunostaining.
Images were taken with a Nikon Eclipse TE2000-U fluorescent microscope (Nikon, Tokyo, Japan). Fluorescence intensities and axon lengths were quantified using an image analysis software (SimplePCI, Compix Inc., Sewickley, PA, USA). Statistical analysis was performed using the paired Student's t test.
Scanning electron microscopy [SEM] was used to investigate the substrate degradation and morphology of cells grown on the different substrates. The cells were fixed with 4% paraformaldehyde in PBS at 4°C for 20 min, followed by a series of ethanol dehydration. Carbon dioxide critical point drying was preformed to avoid specimen distortion during the drying process. The specimens were sputter-coated with a 500-Å gold thin film and examined using FEI Quanta 200 ESEM (FEI Co., Hillsboro, OR, USA).
CNTs have been demonstrated to stimulate neuronal differentiation [6, 8]; however, CNTs are easily disintegrated without supporting matrices and require delicate handling and intensive labor. Here, we used fibroin to provide mechanical and structural support for CNT-based scaffolds (Figure 1b). The amphiphilic properties of natural silk fibroin protein can not only disperse CNTs, but also form a polymer matrix to hold CNTs within its polymer network. In comparison to other hydrogels used in tissue engineering, the fibroin matrix can provide sufficient mechanical strength for transplant applications .
In this study, our results demonstrated the potential of the silk-CNT composite as scaffolds to support neuronal differentiation for regenerative medicine (Figures 1,2,3,4). The silk-CNT composite scaffold hybridizes advantages from both naturally derived and synthetic materials; fibroin provides a mechanically robust matrix and biodegradable properties for tissue transplantation vehicles [8, 13, 15, 17]. Amphiphilic silk protein here not only provides biodegradable matrices to physically incorporate CNTs in the scaffold, but also acts as an effective dispersant to distribute CNTs homogeneously within the matrix, which is a major limitation for CNT applications within hydrophilic networks. Additionally, CNTs embedded in the silk matrix may promote electron signal transmissions between neurons . In comparison to 2-D PLO substrates, the silk-CNT composite increases neuronal differentiation and provides three-dimensional matrices for cell growth. Further observation showed that hESCs cultured on the silk-CNT scaffold exhibited higher maturity along with dense axonal projections. Our results support silk-CNT scaffolds as one viable candidate for nerve repair treatments of patients suffering from SCI or MS.
This study was supported by a grant from the Muscular Dystrophy Association (MDA). EYC, MB, and CSC were supported by the UC Merced GRC summer fellowships, California Sea Grant traineeship, John Isaac summer scholarship, Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities), and Jane Vilas Stem Cell Fellowship.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.